HK1118713A1 - 放射性氟化肽 - Google Patents

放射性氟化肽

Info

Publication number
HK1118713A1
HK1118713A1 HK08110335.5A HK08110335A HK1118713A1 HK 1118713 A1 HK1118713 A1 HK 1118713A1 HK 08110335 A HK08110335 A HK 08110335A HK 1118713 A1 HK1118713 A1 HK 1118713A1
Authority
HK
Hong Kong
Prior art keywords
diagnostic compounds
processes
diagnostic
compounds
radiopharmaceuticals
Prior art date
Application number
HK08110335.5A
Other languages
English (en)
Inventor
Magne Solbakken
Bente Arbo
Alan Cuthbertson
Alexander Gibson
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Publication of HK1118713A1 publication Critical patent/HK1118713A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK08110335.5A 2004-09-14 2008-09-18 放射性氟化肽 HK1118713A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0420344.4A GB0420344D0 (en) 2004-09-14 2004-09-14 Diagnostic compounds
PCT/IB2005/002727 WO2006030291A2 (en) 2004-09-14 2005-09-14 Radiofluorinated peptides

Publications (1)

Publication Number Publication Date
HK1118713A1 true HK1118713A1 (zh) 2009-02-20

Family

ID=33186989

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08110335.5A HK1118713A1 (zh) 2004-09-14 2008-09-18 放射性氟化肽

Country Status (24)

Country Link
US (2) US7875701B2 (zh)
EP (1) EP1791571B1 (zh)
JP (1) JP4949251B2 (zh)
KR (1) KR101243016B1 (zh)
CN (1) CN101151054B (zh)
AT (1) ATE404225T1 (zh)
AU (1) AU2005283904B8 (zh)
BR (1) BRPI0515175A (zh)
CA (1) CA2578470C (zh)
DE (1) DE602005008996D1 (zh)
DK (1) DK1791571T3 (zh)
ES (1) ES2312018T3 (zh)
GB (1) GB0420344D0 (zh)
HK (1) HK1118713A1 (zh)
IL (1) IL181529A (zh)
MX (1) MX2007003019A (zh)
NO (1) NO20071880L (zh)
NZ (1) NZ553384A (zh)
PL (1) PL1791571T3 (zh)
PT (1) PT1791571E (zh)
RU (1) RU2396272C9 (zh)
SI (1) SI1791571T1 (zh)
WO (1) WO2006030291A2 (zh)
ZA (1) ZA200702700B (zh)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4510444B2 (ja) * 2001-07-10 2010-07-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
EP1985624A3 (en) * 2007-04-23 2008-12-24 Bayer Schering Pharma Aktiengesellschaft Single step method of radiofluorination of biologically active compounds or biomolecules
EP2061519B1 (en) 2006-09-15 2016-03-30 Siemens Medical Solutions USA, Inc. Click chemistry-derived cyclopeptide derivatives as imaging agents for integrins
WO2008072976A2 (en) * 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
EP2125039A2 (en) 2006-12-18 2009-12-02 GE Healthcare AS Synthesis of a radiofluorinated peptide using photolabile protecting groups
WO2008083191A2 (en) * 2006-12-28 2008-07-10 Ge Healthcare As Radiofluorination methods
EP2146753A2 (en) * 2007-03-01 2010-01-27 Bayer Schering Pharma Aktiengesellschaft 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof
WO2009035959A2 (en) * 2007-09-10 2009-03-19 Ge Healthcare Limited Radiofluorination methods
WO2009108484A1 (en) 2008-02-28 2009-09-03 Ge Healthcare Limited Synthesis of a peg-6 moiety from commercial low-cost chemicals
GB0905438D0 (en) * 2009-03-30 2009-05-13 Ge Healthcare Ltd Radiolabelling reagents and methods
US8834839B2 (en) * 2009-04-27 2014-09-16 General Electric Company Labeled molecular imaging agents, methods of making and methods of use
GB0910013D0 (en) * 2009-06-10 2009-07-22 Ge Healthcare Ltd PET imaging of fibogenesis
WO2011084763A1 (en) 2009-12-21 2011-07-14 Ge Healthcare Limited Borosilicate glassware and silica based qma's in 18f nucleophilic substitution: influence of aluminum, boron and silicon on the reactivity of the 18f ion
GB201013808D0 (en) 2010-08-18 2010-09-29 Ge Healthcare Ltd Peptide radiotracer compositions
CA2819347A1 (en) 2010-12-01 2012-06-07 Ge Healthcare Limited Radioconjugation method
CA2820387A1 (en) * 2010-12-09 2012-06-14 Ge Healthcare Limited Radiotracer compositions
AU2011349698A1 (en) * 2010-12-21 2013-07-25 Ge Healthcare Limited Use of aniline in the radiostabilization of oxime ligation
US20130074758A1 (en) 2011-09-26 2013-03-28 Ocean Power Technologies, Inc. Anchoring apparatus for wave energy converters
WO2013048996A1 (en) 2011-09-30 2013-04-04 Ge Healthcare Limited Method for the purification of a peptide-based imaging agent precursor
WO2013048956A2 (en) * 2011-09-30 2013-04-04 Ge Healthcare Limited Solid phase extraction separation method
GB201202420D0 (en) * 2012-02-13 2012-03-28 Ge Healthcare Ltd Radiotracer compositions
GB201221266D0 (en) 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
KR102205845B1 (ko) 2013-10-28 2021-01-22 삼성전자주식회사 입자에 기반한 모델링 방법 및 장치
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
KR102458116B1 (ko) 2014-12-04 2022-10-24 지이 헬쓰케어 리미티드 방사성 약제로부터의 아세트알데히드의 제거 방법
GB201518918D0 (en) * 2015-10-26 2015-12-09 Norsk Medisinsk Syklotronsenter As And Uni I Oslo Method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4510444B2 (ja) * 2001-07-10 2010-07-21 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
GB0206750D0 (en) * 2002-03-22 2002-05-01 Amersham Plc Radiofluorination methods
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0317815D0 (en) * 2003-07-30 2003-09-03 Amersham Health As Imaging agents

Also Published As

Publication number Publication date
PT1791571E (pt) 2008-11-19
EP1791571B1 (en) 2008-08-13
CA2578470C (en) 2015-09-01
NZ553384A (en) 2011-02-25
WO2006030291A3 (en) 2007-06-14
RU2396272C2 (ru) 2010-08-10
AU2005283904B8 (en) 2012-02-23
KR101243016B1 (ko) 2013-03-12
JP4949251B2 (ja) 2012-06-06
ES2312018T3 (es) 2009-02-16
KR20070053750A (ko) 2007-05-25
CA2578470A1 (en) 2006-03-23
MX2007003019A (es) 2007-08-07
NO20071880L (no) 2007-06-13
BRPI0515175A (pt) 2008-07-08
US8563600B2 (en) 2013-10-22
IL181529A0 (en) 2007-07-04
GB0420344D0 (en) 2004-10-13
RU2007108762A (ru) 2008-10-27
ZA200702700B (en) 2008-09-25
AU2005283904A1 (en) 2006-03-23
EP1791571A2 (en) 2007-06-06
PL1791571T3 (pl) 2009-01-30
DK1791571T3 (da) 2008-12-08
SI1791571T1 (sl) 2009-02-28
CN101151054A (zh) 2008-03-26
US20110117016A1 (en) 2011-05-19
JP2008516894A (ja) 2008-05-22
AU2005283904B2 (en) 2012-01-19
ATE404225T1 (de) 2008-08-15
WO2006030291A2 (en) 2006-03-23
DE602005008996D1 (de) 2008-09-25
CN101151054B (zh) 2014-09-24
RU2396272C9 (ru) 2010-12-10
US7875701B2 (en) 2011-01-25
IL181529A (en) 2015-04-30
US20080095701A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
IL181529A0 (en) Diagnostic compounds
CY1118199T1 (el) Ενωσεις υποκατεστημενης πυραζολο[1,5] πυριμιδινης ως ενδιαμεσα στη συνθεση αναστολεων κινασης trk
PH12013500365A1 (en) Anti-infective agents and uses thereof
TW200732335A (en) Organic compounds
TW200800999A (en) Novel compounds
UA94833C2 (en) Substituted bicyclolactams
TW200745114A (en) Novel compounds
CR10157A (es) Compuestos químicos
MX2010002902A (es) Pirimidinas anti-infecciosas y usos de las mismas.
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
MX2008001799A (es) Composicion farmaceutica que comprende un inhibidor de dipeptidil peptidasa iv.
MX2010004493A (es) Compuestos de tropano.
TW200716529A (en) New compounds II
TW200732337A (en) Organic compounds
TW200745122A (en) New compounds I
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
TW200800967A (en) Benzimidazole thiophene compounds
MX2009002492A (es) Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
TW200736227A (en) New compounds III
TW200718698A (en) Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof
TW200800986A (en) Tetrahydroquinolines, synthesis thereof, and intermediates thereto
TW200738713A (en) Diazepinoquinolines, synthesis thereof, and intermediates thereto
WO2009035959A3 (en) Radiofluorination methods
TW200744612A (en) New combination
TW200745133A (en) New compounds II

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180914